Good Evening Market Enthusiast,

Some stories stay quiet. This one does not.

Tomorrow’s 8AM drop centers on a tiny float biotech with an FDA approved cancer therapy that is about to ship. Commercial batches are ready. Shelf life is long. Distribution is set. A focused field team is already targeting the prescribers who matter.

This is not a someday promise. It is commercial ready with timelines you can see.

The float is scarce. Street targets point well above recent levels. That is before revenue shows up.

There is more. The parent still owns the lion’s share of its oncology spin off. The market values that spin off at a level that makes the parent’s quote look out of sync. Hidden equity, hiding in plain sight.

A second therapy tracks toward a filing that can lead to a fast review next year. A third program aims at a large everyday problem where no prescription cream exists today.

Why this has our attention tonight

✅ Real product with an FDA nod
✅ Near term catalysts with visible dates
✅ Lean cap table and insider alignment
✅ Spin off stake that could unlock value

Tomorrow morning we walk through the full story. Clear backdrop. Clear catalysts. Full receipts.

Set your alarms for 8AM EST. Do not be the one asking how you missed it.

To your continued success,

Max Masters

Co-founder, Market Tips Newsletter

Paid Promotion. Please read Momentum Media LLC’s complete disclaimer at https://markettips.net/disclaimer/ which includes important information. Emojis, graphics and/or images used herein have no specific or implied meaning, and are used for artistic purposes only. Nothing contained herein is fina.ncial advice. Momentum Media LLC is not an analyst, st.o.ck broker, fina.ncial adviser or st.o.ck picker nor is it qualified to act in the capacity of any of the foregoing. Information herein is a paid advertisement and should not be relied upon as accurate or complete.